Taken together, the increased expression of ESR2, combined with the reduced expression of key mitochondrial and antioxidant regulators, suggests that obesity-related inflammation enhances the aggressive phenotype of luminal breast cancer through a compromised mitochondrial and antioxidant response. Here, ESR2 is linked to obesity due to melanocortin 4 receptor deficiency.